Robert D. Hawkins

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text

Medicine, Oncology, Pharmacology +9

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, David Cella et al. · New England Journal of Medicine · 2013 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +13

Control of Memory Formation Through Regulated Expression of a CaMKII Transgene

Mark Mayford, Mary Elizabeth Bach, Yan-You Huang et al. · Science · 1996 · 1.6K citations

Life Sciences, Genetics, Neuroscience +17

Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.

Thomas J. O’Dell, Robert D. Hawkins, Eric R. Kandel et al. · Proceedings of the National Academy of Sciences · 1991 · 1K citations

Life Sciences, Neurobiology, Neuroscience +17